Gene Editing Industry Statistics

In this post, we will explore the dynamic landscape of the gene editing industry, backed by a range of compelling statistics. From market size growth projections to regional market shares and public perception, these key figures provide valuable insights into the industry’s evolution and potential impact on healthcare and biotechnology sectors.

Statistic 1

"Gene Editing Market size surpassed USD 3 billion in 2017."

Statistic 2

"Gene Editing Market Expect to Register a CAGR of 18.30% By 2023."

Statistic 3

"North America accounted for the largest share of the global gene-editing market in 2019."

Statistic 4

"The largest application of gene editing is in cancer treatment, accounting for 26% of the market."

Statistic 5

"Reproductive medicine application is projected to grow at a significant CAGR of over 22% between 2021 and 2027."

Statistic 6

"The Asia Pacific market will register a 14.9% growth rate through to 2027."

Statistic 7

"Vitamin production is projected to show growth at a CAGR of 9.1% during the forecast period."

Statistic 8

"72% of Americans accept the use of gene editing to treat diseases."

Statistic 9

"Over the last five years, the gene editing industry has grown by 16.9%."

Statistic 10

"The genome editing/gene therapy market is expected to reach $11.2 billion by 2025."

Statistic 11

"The CRISPR technology segment accounted for the largest share of the gene-editing market in 2019."

Statistic 12

"The USA gene editing market size was valued at $518 million in 2018."

Statistic 13

"Contract services held over 30% Gene Editing Market share in 2020."

Statistic 14

"40% of Americans believe gene editing will lead to increased inequality."

Statistic 15

"By the end of 2023, the value of the global gene editing market is estimated to be US$7.5 bn."

Statistic 16

"Over 60% of global gene editing revenue in 2018 was generated by North America."

Statistic 17

"The global gene editing market was valued at $3.7 billion in 2018."

Statistic 18

"Advancements in technology are expected to propel the gene editing market growth at a CAGR of 17.2% during the forecast period 2017-2023."

The gene editing industry has experienced significant growth in recent years, with the market size surpassing USD 3 billion in 2017 and expected to reach $11.2 billion by 2025. North America has dominated the market, especially in the CRISPR technology segment, while the Asia Pacific region is poised for substantial growth. Cancer treatment remains the primary application of gene editing, but reproductive medicine is projected to see significant growth. Despite positive trends, concerns around inequality and ethical considerations persist among a portion of the population. Overall, advancements in technology are driving the industry forward, with a strong projected compound annual growth rate and expanding market value anticipated in the coming years.